Tracking and contextualizing trending narratives across the nation's most pressing health topics

The Monitoring Lab is currently providing regular insights and real-time data dashboards on the four topics below. Select your topic of interest and area of practice to access data and insights tailored to your work.

Regular insights

United States

Vaccines: Public health

Vaccines: Health care

Substance use

Mental health

Reproductive health

Latin America & Caribbean

Vaccines

Europe

Vaccines

The insights on these pages are based on the monitoring of publicly available data. While some insights reference specific false claims and conspiracy theories, others are included to indicate gaps in knowledge, concerns, speculation, and other trending narratives related to the topic. Inclusion in reporting is based on reach and velocity of spread and on whether conversations may impact health behaviors and decisions.

Tracking all publicly available media data, our monitoring systems provide real-time intelligence on the health narratives trending across the country.

Dashboards are currently active across four health topics in the U.S. Click a topic below to explore the data at the national and regional levels.

Original reporting

Read in-depth reports from science journalists

Women are talking about menopause online. Here’s what they’re asking.

Online conversations reveal frustration with providers and persistent gaps in reliable information online.

"Everyone Zyns now": What NYC's online conversations reveal about nicotine pouch culture

Posts highlight misconceptions about health risks, wellness claims, and a strong social identity around nicotine pouches.

How AI chatbots are changing the way young people seek mental health support

Young people are turning to AI for mental health support. Here’s what they have to say.

“I am speechless”: Health care providers react to unproven link between Tylenol and autism

Analysis of Reddit and X conversations shows providers expressing concern for patients and frustration with new federal guidance.